Home » Topics » Hematologic, BioWorld Science

Hematologic, BioWorld Science
RSS

Merck reports the identification of a surprisingly potent and selective thrombin inhibitor

April 8, 2003

Ongoing program for clopidogrel in atherosclerosis

April 7, 2003

Results of argatroban and gpIIb/IIIa inhibitor combination study

April 7, 2003

BMS identifies new factor VIIa inhibitors

April 4, 2003

Phase III program to assess fondaparinux in acute coronary syndromes

April 3, 2003

Alfimeprase safe and well tolerated in phase I

March 31, 2003

New factor Xa inhibitors synthesized by Merck KGaA

March 27, 2003

New thrombolytic carboxypeptidase U inhibitors in early development at Merck

March 26, 2003

Newly discovered thrombin inhibitors patented by Merck

March 21, 2003

Novel platelet ADP receptor inhibitors in Millennium development pipeline

March 21, 2003

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 8, 2026.
Hyperexcitability may be joint problem in epilepsy, dementia
BioWorld
The majority of epilepsies are developmental disorders that start in childhood. But there is a large minority that starts in late adulthood. And increasingly,...
‘Target-high but uptake-defective’ state identified in ADC resistance
BioWorld
Separate research teams have reported new insights into resistance mechanisms to the antibody-drug conjugate (ADC) Padcev (enfortumab vedotin, Astellas Pharma...
Neurovalens granted FDA approval for PTSD therapy for US veterans
BioWorld
Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...
In the clinic for July 6, 2026
BioWorld
Clinical updates for biopharma and med tech, including data readouts and publications: Arcus, Genentech, Merck, Myriad, Otsuka, Partner, Revolution, Treos.